Vaccine therapies

Hong Qin; Sattva S. Neelapu; Alison F. Woo; Soung Chul Cha; Larry W. Kwak

doi:10.1201/b13424

Vaccine therapies

Hong Qin, Sattva S. Neelapu, Alison F. Woo, Soung Chul Cha, Larry W. Kwak

Hematology / Oncology / Cancer Center / Breast Clinic

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The development of therapeutic vaccines against human malignancies has been a long-sought goal. Many efforts toward this end have been frustrated by the lack of identified, tumor-specific antigens that would allow tumor cells to be distinguished from normal cells. Conceptually, such an antigen could be used as an immunogen to activate host antitumor immunity.

Original language	English (US)
Title of host publication	The Lymphoid Neoplasms 3ed
Publisher	CRC Press
Pages	1540-1551
Number of pages	12
ISBN (Electronic)	9781444113228
ISBN (Print)	9780340809471
DOIs	https://doi.org/10.1201/b13424
State	Published - Jan 1 2010

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1201/b13424

Cite this

@inbook{e7c764d08aa3466abe3e83be63f6e429,

title = "Vaccine therapies",

abstract = "The development of therapeutic vaccines against human malignancies has been a long-sought goal. Many efforts toward this end have been frustrated by the lack of identified, tumor-specific antigens that would allow tumor cells to be distinguished from normal cells. Conceptually, such an antigen could be used as an immunogen to activate host antitumor immunity.",

author = "Hong Qin and Neelapu, {Sattva S.} and Woo, {Alison F.} and Cha, {Soung Chul} and Kwak, {Larry W.}",

note = "Publisher Copyright: {\textcopyright} 2010 by Taylor & Francis Group, LLC.",

year = "2010",

month = jan,

day = "1",

doi = "10.1201/b13424",

language = "English (US)",

isbn = "9780340809471",

pages = "1540--1551",

booktitle = "The Lymphoid Neoplasms 3ed",

publisher = "CRC Press",

}

TY - CHAP

T1 - Vaccine therapies

AU - Qin, Hong

AU - Neelapu, Sattva S.

AU - Woo, Alison F.

AU - Cha, Soung Chul

AU - Kwak, Larry W.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - The development of therapeutic vaccines against human malignancies has been a long-sought goal. Many efforts toward this end have been frustrated by the lack of identified, tumor-specific antigens that would allow tumor cells to be distinguished from normal cells. Conceptually, such an antigen could be used as an immunogen to activate host antitumor immunity.

AB - The development of therapeutic vaccines against human malignancies has been a long-sought goal. Many efforts toward this end have been frustrated by the lack of identified, tumor-specific antigens that would allow tumor cells to be distinguished from normal cells. Conceptually, such an antigen could be used as an immunogen to activate host antitumor immunity.

UR - http://www.scopus.com/inward/record.url?scp=85056063894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056063894&partnerID=8YFLogxK

U2 - 10.1201/b13424

DO - 10.1201/b13424

M3 - Chapter

AN - SCOPUS:85056063894

SN - 9780340809471

SP - 1540

EP - 1551

BT - The Lymphoid Neoplasms 3ed

PB - CRC Press

ER -

Vaccine therapies

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this